Theranos promised to revolutionize the healthcare industry, raised nearly $1B in funding, attained a $9B valuation, and assembled a high-powered board of directors of former secretaries of state, secretaries of defense, 4-star generals, and senators. Tyler was 22 years old, fresh out of college, and eager to join a company that was being touted as "the Apple of healthcare." He quickly realized, however, that behind the facade of a charismatic founder, powerful board, high-profile investors, and magazine cover stories, Theranos was built on lies. Tyler raised concerns to colleagues, managers, a VP, the President and COO, the CEO, and a Board Member before reaching out to government regulators and the Wall Street Journal to expose one of the biggest corporate frauds since Enron.

After Theranos, Tyler has continued to pursue the vision of delivering high quality, actionable diagnostic solutions.  He co-founded two startups in the diagnostics field: one is a deep-tech lab-on-a-chip venture spun out of the Center for Magnetic Nanotechnology at Stanford, and the other is a direct-to-consumer company utilizing dried blood spot testing.

Tyler now speaks to audiences all over the world on the importance of implementing ethics and compliance into companies, and how they can be used as competitive advantages.